Skip to main content Skip to main navigation menu Skip to site footer

Diagnosing and treating Patent Foramen Ovale (PFO) from various manifestations in adults: case series



Abstract

Background. Patent foramen ovale (PFO) is a part of atrial septal defects (ASD) entities. While mostly asymptomatic, some adults with PFO will develop symptoms, from mild complaints such as migraine or palpitation to more debilitating complications such as syncope or cryptogenic stroke. Therefore, it is highly crucial that PFO be diagnosed and treated promptly. Echocardiography, trans-thoracal and or trans-esophageal, is the main diagnosis modality. For treatment, antiplatelet with or without anticoagulation, trans-catheter closure, and surgery are utilized in accordance with their indications.

Case Presentation. We present four adult patients referred with various symptoms: vertigo, migraine, palpitation, and cryptogenic stroke. Three of them had no explicit risk factors for the cerebrovascular event, with one patient having a co-existing hypercoagulable state. Echocardiography revealed a positive bubble test, which meant that PFO was the primary etiology of those cases. We then treated each of them with transcatheter device closure, which improved their symptoms, before adding antiplatelet for six months.

Conclusion. Proper diagnosis and prompt treatment of PFO are imperative in reducing complications. Echocardiography, mainly TEE, is the main diagnostic tool for PFO. Antithrombotic (with or without anticoagulant), minimally invasive procedure and surgery in some cases are the modalities available.

Keywords: adults manifestations patent foramen ovale transcatheter closure

References

  1. Connuck D, Sun JP, Super DM, et al. Incidence of patent ductus arteriosus and patent foramen ovale in normal infants. Am J Cardiol. 2002;89(2):244-247. doi:10.1016/s0002-9149(01)02214-7.
  2. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17-20. doi:10.1016/s0025-6196(12)60336-x.
  3. Das BB. Patent Foramen Ovale in Fetal Life, Infancy and Childhood. Med Sci (Basel). 2020;8(3):25. Published 2020 Jul 1. doi:10.3390/medsci8030025.
  4. Kutty S, Sengupta PP, Khandheria BK. Patent foramen ovale: the known and the to be known. J Am Coll Cardiol. 2012;59(19):1665-1671. doi:10.1016/j.jacc.2011.09.085.
  5. Bang OY, Lee MJ, Ryoo S, Kim SJ, Kim JW. Patent Foramen Ovale and Stroke-Current Status. J Stroke. 2015;17(3):229-237. doi:10.5853/jos.2015.17.3.229.
  6. Ghosh AK, Jain A. Diagnosis and management of patent foramen ovale. Br J Hosp Med (Lond). 2015;76(7):C98-C102. doi:10.12968/hmed.2015.76.7.C98.
  7. Remien K, Majmundar SH. Physiology, fetal circulation. [Updated 2021 July 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK539710/ PMID: 30969532.
  8. Hampton T, Alsaleem M, Murphy-Lavoie HM. Patent Foramen Ovale. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 10, 2021.
  9. Bandinelli C, Puddu G, Balducci A, Bianchi G, Zoli M. Congenital cardiac defects, such as Eustachian Valve, may increase the risk of cryptogenic stroke: a case report. World Journal of Cardiovascular Diseases. 2020; 10:379-84. doi: 10.4236/wjcd.2020.106036.
  10. Collado FMS, Poulin MF, Murphy JJ, Jneid H, Kavinsky CJ. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders. J Am Heart Assoc. 2018;7(12):e007146. Published 2018 Jun 17. doi:10.1161/JAHA.117.007146.
  11. O'Gara PT, Messe SR, Tuzcu EM, et al. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. Circulation. 2009;119(20):2743-2747. doi:10.1161/CIRCULATIONAHA.109.192272.
  12. Wu LA, Malouf JF, Dearani JA, et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med. 2004;164(9):950-956. doi:10.1001/archinte.164.9.950.
  13. Guercini F, Acciarresi M, Agnelli G, Paciaroni M. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost. 2008;6(4):549-554. doi:10.1111/j.1538-7836.2008.02903.x.
  14. Saver JL. Cryptogenic stroke. N Engl J Med. 2016; 375:e26. doi: 10.1056/NEJMc1609156.
  15. Reisman M, Fuller CJ. Is patent foramen ovale closure indicated for migraine?: patent foramen ovale closure for migraine. Circ Cardiovasc Interv. 2009;2(5):468-474. doi:10.1161/CIRCINTERVENTIONS.109.876128.
  16. Rana BS, Thomas MR, Calvert PA, Monaghan MJ, Hildick-Smith D. Echocardiographic evaluation of patent foramen ovale prior to device closure. JACC Cardiovasc Imaging. 2010;3(7):749-760. doi:10.1016/j.jcmg.2010.01.007.
  17. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology. 1999;52(8):1622-1625. doi:10.1212/wnl.52.8.1622.
  18. Søndergaard L, Kasner SE, Rhodes JF, et al. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke [published correction appears in N Engl J Med. 2020 Mar 5;382(10):978]. N Engl J Med. 2017;377(11):1033-1042. doi:10.1056/NEJMoa1707404.
  19. Mas JL, Derumeaux G, Guillon B, et al. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. N Engl J Med. 2017;377(11):1011-1021. doi:10.1056/NEJMoa1705915.
  20. Lee PH, Song JK, Kim JS, et al. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial. J Am Coll Cardiol. 2018;71(20):2335-2342. doi:10.1016/j.jacc.2018.02.046.
  21. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014 Jun 10;129(23):e650]. Circulation. 2014;129(23):2440-2492. doi:10.1161/CIR.0000000000000029.

How to Cite

Silalahi, T. D. A., Suwita, C. S., Darmawan, R. O., & Rosalie, B. (2022). Diagnosing and treating Patent Foramen Ovale (PFO) from various manifestations in adults: case series. Bali Medical Journal, 11(1), 405–409. https://doi.org/10.15562/bmj.v11i1.2779
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
22

Share

Search Panel

Todung Donald Aposan Silalahi
Google Scholar
Pubmed
BMJ Journal

Christopher Surya Suwita
Google Scholar
Pubmed
BMJ Journal

Rosaria Oktafiani Darmawan
Google Scholar
Pubmed
BMJ Journal

Benita Rosalie
Google Scholar
Pubmed
BMJ Journal